TC BioPharm

/TC BioPharm

IPO

TC BioPharm

Biopharmaceutical

TCB based in Scotland, is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

Symbol

TCBP

Price Range
$8.00 - $8.00

Final Shares
3,750,000

Anticipated Date
January 28, 2022

Underwriters
EF Hutton

This offering is no longer available

To view the prospectus for TC BioPharm IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange